Dataset Information

Normalized relative abundance measurement of amines in B. fragilis culture using GC-EI-MS with methoxyamine and TMS derivatization from 'Microbially-catalyzed conjugation of GABA and tyramine to bile acids'

ABSTRACT: Normalized relative abundance measurement of amines in B. fragilis P207 (NCBI accession NZ_CP114371) culture using GC-EI-MS with methoxyamine and TMS derivatization.

INSTRUMENT(S): Agilent 7890B/5977B GC/MS with Electron Impact Ionization (EI)

ORGANISM(S): Bacteroides Fragilis P207

SUBMITTER: Sean Crosson

PROVIDER: MSV000093030 | MassIVE | Wed Oct 04 09:49:00 BST 2023

REPOSITORIES: MassIVE

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Bile acids (BAs) are cholesterol-derived molecules that aid in digestion and nutrient absorption, regulate host metabolic processes, and influence physiology of the gut microbiota. Both the host and its microbiome contribute to enzymatic modifications that shape the chemical diversity of BAs in the gut. Several bacterial species have been reported to conjugate standard amino acids to BAs, but it was not known if bacteria conjugate BAs to other amine classes. Here, we show that Bacteroides fragilis strain P207, isolated from a bacterial bloom in the J-pouch of a patient with ulcerative colitis pouchitis, conjugates standard amino acids and the neuroactive amines γ-aminobutyric acid (GABA) and tyramine to deoxycholic acid. We extended this analysis to other human gut isolates and identified species that are competent to conjugate GABA and tyramine to primary and secondary BAs, and further identified diverse BA-GABA and BA-tyramine amides in human stool. A longitudinal metabolomic analysis of J-pouch contents of the patient from whom B. fragilis P207 was isolated revealed highly reduced levels of secondary bile acids and a shifting BA amide profile before, during, and after onset of pouchitis, including temporal changes in several BA-GABA amides. Treatment of pouchitis with ciprofloxacin was associated with a marked reduction of nearly all BA amides in the J-pouch. Our study expands the known repertoire of conjugated bile acids produced by bacteria to include BA conjugates to GABA and tyramine and demonstrates that these molecules are present in the human gut. IMPORTANCE BAs are modified in multiple ways by host enzymes and the microbiota to produce a chemically diverse set of molecules that assist in the digestive process and impact many physiological functions. This study reports the discovery of bacterial species that conjugate the neuroactive amines, GABA and tyramine, to primary and secondary BAs. We further present evidence that BA-GABA and BA-tyramine conjugates are present in the human gut, and document a shifting BA-GABA profile in a human pouchitis patient before, during, and after inflammation and antibiotic treatment. GABA and tyramine are common metabolic products of the gut microbiota and potent neuroactive molecules. GABA- and tyramine-conjugated BAs may influence receptor-mediated regulatory mechanisms of humans and their gut microbes, and absorption of these molecules and their entry into enterohepatic circulation may impact host physiology at distal tissue sites. This study defines new conjugated bile acids in the human gut.

Dataset Information

Normalized relative abundance measurement of amines in B. fragilis culture using GC-EI-MS with methoxyamine and TMS derivatization from 'Microbially-catalyzed conjugation of GABA and tyramine to bile acids'

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets